The therapeutic revolution of anti-amyloid antibodies for Alzheimer's disease

By specifically targeting amyloid plaques, considered to be one of the main factors in this neurodegenerative pathology, these therapies open up new prospects for slowing disease progression and improving patients' quality of life.